Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Toes

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Journal of Immunological Methods|October 19, 1992
A rapid isolation procedure for dendritic cells from mouse spleen by centrifugal elutriationM A Ossevoort, R E Toes, M L De Bruijn, et al.
Immunology Letters|July 1, 1995
Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilizationM C Feltkamp, M P Vierboom, R E Toes, et al.
Behring Institute Mitteilungen|July 1, 1994
Tumor rejection antigens and tumor specific cytotoxic T lymphocytesR E Toes, R Offringa, M C Feltkamp, et al.
Journal of Virology|November 13, 1999
Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subsetD Rea, F H Schagen, R C Hoeben, et al.
Journal of Immunological Methods|July 6, 1993
In vivo detection of fluorescent tumor-specific cytotoxic T cell clonesR E Toes, J M den Haan, M C Feltkamp, et al.
Cancer Research|July 29, 1998
Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APCS P Schoenberger, L E Jonges, R J Mooijaart, et al.
Seminars in Immunology|November 5, 1997
Activation or frustration of anti-tumor responses by T-cell-based immune modulationR E Toes, S P Schoenberger, E I van der Voort, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogeneR E Toes, R Offringa, R J Blom, et al.
Immunotechnology : an International Journal of Immunological Engineering|November 1, 1996
Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunityM E Ressing, R Offringa, R E Toes, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashionR E Toes, R C Hoeben, E I van der Voort, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Immunological Methods|October 19, 1992
A rapid isolation procedure for dendritic cells from mouse spleen by centrifugal elutriationM A Ossevoort, R E Toes, M L De Bruijn, et al.
Immunology Letters|July 1, 1995
Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilizationM C Feltkamp, M P Vierboom, R E Toes, et al.
Behring Institute Mitteilungen|July 1, 1994
Tumor rejection antigens and tumor specific cytotoxic T lymphocytesR E Toes, R Offringa, M C Feltkamp, et al.
Journal of Virology|November 13, 1999
Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subsetD Rea, F H Schagen, R C Hoeben, et al.
Journal of Immunological Methods|July 6, 1993
In vivo detection of fluorescent tumor-specific cytotoxic T cell clonesR E Toes, J M den Haan, M C Feltkamp, et al.
Cancer Research|July 29, 1998
Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APCS P Schoenberger, L E Jonges, R J Mooijaart, et al.
Seminars in Immunology|November 5, 1997
Activation or frustration of anti-tumor responses by T-cell-based immune modulationR E Toes, S P Schoenberger, E I van der Voort, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogeneR E Toes, R Offringa, R J Blom, et al.
Immunotechnology : an International Journal of Immunological Engineering|November 1, 1996
Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunityM E Ressing, R Offringa, R E Toes, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashionR E Toes, R C Hoeben, E I van der Voort, et al.
Pageof 6